Angelo Fedele Scinto

A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: a real-world experience

Patrizia Vici, Laura Pizzuti, Andrea Michelotti et al. · Oncotarget · 2017 · 68 citations · Full text

Fluorouracil and dose-dense adjuvant chemotherapy in patients with early-stage breast cancer (GIM2): end-of-study results from a randomised, phase 3 trial

Lucia Del Mastro, Francesca Poggio, Eva Blondeaux et al. · The Lancet Oncology · 2022 · 46 citations

End-of-study Results, Breast Oncology, Early-stage Breast Cancer +6

“Triple positive” early breast cancer: an observational multicenter retrospective analysis of outcome

Patrizia Vici, Laura Pizzuti, Isabella Sperduti et al. · Oncotarget · 2016 · 43 citations · Full text

A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study

Teresa Gamucci, Laura Pizzuti, Clara Natoli et al. · Cancer Biology & Therapy · 2018 · 42 citations · Full text

Mitomycin C plus vindesine plus etoposide (MEV) versus mitomycin C plus vindesine plus cisplatin (MVP) in stage IV non-small-cell lung cancer: A phase III multicentre randomised trial

Cesare Gridelli, François Perron, S. Palmeri et al. · Annals of Oncology · 1996 · 33 citations

Mitomycin C, Medicine, Bronchial Neoplasm +9